Orthopediatrics (KIDS) 10% Owner David R. Pelizzon Sells Shares

What Happened
David R. Pelizzon, reported as a 10% owner, sold a total of 38,300 shares of Orthopediatrics (KIDS) in three open‑market transactions on Aug 24–26, 2026. The sales were: 4,000 shares at a weighted average $25.75 (≈ $103,000), 16,300 shares at a weighted average $24.74 (≈ $403,262), and 18,000 shares at a weighted average $24.28 (≈ $437,040), for combined proceeds of about $943,302. These were sales (S), not purchases.

Key Details

• Transaction dates and prices:
  • 2026-08-24: 4,000 shares @ $25.75 (weighted avg; range $25.50–$25.82) — F2
  • 2026-08-25: 16,300 shares @ $24.74 (weighted avg; range $24.53–$24.88) — F4
  • 2026-08-26: 18,000 shares @ $24.28 (weighted avg; range $24.13–$24.36) — F5
• Total proceeds: ≈ $943,302.
• Filing: Report filed 2026-08-26 covering trades 8/24–8/26 — appears timely under Section 16 reporting rules.
• Holdings/beneficial ownership notes: Filing indicates these shares are (or were) held by Squadron Capital LLC. Pelizzon is President and a Managing Committee member of Squadron and "may be deemed" a beneficial owner but disclaims beneficial ownership except for any pecuniary interest — F3. The filing also notes restricted stock awards totaling 17,959 shares are included in reported holdings — F6.
• Motive note from filing: Squadron Capital LLC states the sale was to provide additional capital for other portfolio businesses — F1.

Context
These were open‑market sales by an entity-affiliated 10% owner (Squadron Capital LLC) rather than a clear insider purchase signal. Weighted average prices and disclosed ranges mean the shares were sold in multiple executions. Sales by large holders can reflect fund rebalancing or capital needs; they are factual transactions and don’t by themselves indicate company prospects.